Document 2683 DOCN M94A2683 TI A newly-developed immunofluorescence assay for simultaneous detection of antibodies to human immunodeficiency virus type 1 and type 2. DT 9412 AU Tanabe-Tochikura A; Singh MT; Tsuchie H; Zhang J; Mattunda SM; Paladin FJ; Kurimura T; Dept. of Pathology, Osaka Univ., Suita, Japan. SO Int Conf AIDS. 1994 Aug 7-12;10(1):249 (abstract no. PB0424). Unique Identifier : AIDSLINE ICA10/94369892 AB OBJECTIVE: Immunofluorescence assay (IFA) which is capable of simultaneously detecting antibodies against closely related HIV-1 and HIV-2 was established and evaluated for the ability to serologically discriminate HIV-1 and HIV-2 infections. METHODS: IFA employing three types of cells, HIV-1-infected (U937/LAI), HIV-2-infected (Multinucleated giant cells which were formed by cocultivation of MOLT-4#8 and MOLT-4/GH-1) and uninfected (HeLa) cells whose morphology varies within one field of microscopy was performed. Serum specimens from 95 HIV-1-infected, 26 HIV-2-infected and 3 HIV-1/HIV-2 dually-infected individuals and 106 seronegative blood donors were tested using above mentioned cells. RESULTS: All the samples from individuals infected with HIV were confirmed to contain antibodies to HIV-1 and/or HIV-2. None of the sera from blood donors were positive. Serum specimens from HIV-1-infected or HIV-2-infected individuals were diagnosed as infections with HIV-1 (85/95) and HIV-2 (22/26), respectively. Other 14 (10/95 and 4/26) were shown to be seropositive for both HIV-1-infected and HIV-2-infected cells. DISCUSSION AND CONCLUSION: Our results of newly-developed IFA was capable of distinguishing most (88%) of HIV-1 and HIV-2 infections at one time. This assay appears to be useful for screening as well as for confirming of both HIV-1 and HIV-2 infections simultaneously. DE AIDS Serodiagnosis/*METHODS Cell Line *Fluorescent Antibody Technique Giant Cells/MICROBIOLOGY Hela Cells Human HIV Antibodies/*BLOOD HIV Seropositivity/*DIAGNOSIS/IMMUNOLOGY HIV-1/*IMMUNOLOGY HIV-2/*IMMUNOLOGY Predictive Value of Tests MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).